[SCHEDULE 13G/A] Forte Biosciences, Inc. SEC Filing

Rhea-AI Filing Summary

Federated Hermes, Inc. and affiliated reporting persons disclosed beneficial ownership of 1,635,380 shares of Forte Biosciences, Inc. common stock, representing 13.15% of the class as of the event date. The filing lists Federated Hermes, Inc. (a Pennsylvania entity) and the Voting Shares Irrevocable Trust as holders with sole voting and dispositive power over the 1,635,380 shares, while three individuals — Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue — are reported with shared voting and dispositive power over the same aggregate amount.

The statement affirms the securities were acquired and are held in the ordinary course of business and were not acquired with the purpose of changing or influencing control of the issuer. The filing includes exhibits for classification of reporting persons, a joint filing agreement, and a power of attorney.

Positive

• Material ownership disclosure shows transparency with a 13.15% stake reported
• Clear voting and dispositive powers are specified: Federated Hermes and the Trust report sole power over 1,635,380 shares
• Statement of ordinary-course ownership clarifies the shares were not acquired to change control

Negative

• Single institutional holder at 13.15% concentrates ownership and could influence voting outcomes
• Potential market impact on float and liquidity given a >10% block of outstanding shares
• Future filings may change if the holder's intent shifts (13G to 13D), creating uncertainty for investors

Insights

Corporate Governance Specialist

13.15% stake is a material block that triggers governance visibility.

The disclosed stake of 1,635,380 shares representing 13.15% is large enough to require continued disclosure and will draw attention from boards and investors because it exceeds common block thresholds for activism or influence.

This filing explicitly states the shares are held in the ordinary course and not for control; nevertheless, governance interactions or voting coordination are practical dependencies to monitor during the next annual meeting or any proxy contests in the coming 12 months.

Investor Relations Analyst

Stake size materially affects investor ownership profile and liquidity considerations.

A 13.15% ownership position by a single institutional holder changes the public float composition and can affect share liquidity and short‑term trading dynamics. The filing names Federated Hermes, Inc. and a trust as the principal holders with clear voting/dispositive powers.

Watch for any updates to the filing class (Schedule 13D/A vs 13G) or amendments within 30–90 days, and review any related press or proxy materials that could indicate changes in intent or planned engagement.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Forte Biosciences, Inc.

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

34962G208

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Federated Hermes, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,635,380.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,635,380.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,635,380.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.15 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Voting Shares Irrevocable Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,635,380.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,635,380.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,635,380.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.15 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Thomas R. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,635,380.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,635,380.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,635,380.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.15 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Ann C. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,635,380.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,635,380.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,635,380.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.15 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

J. Christopher Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 1,635,380.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 1,635,380.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,635,380.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

13.15 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Forte Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 3060 Pegasus Park Drive, Building 6 Dallas, TX 75247
Item 2.
(a)	Name of person filing: Federated Hermes, Inc.
(b)	Address or principal business office or, if none, residence: 1001 Liberty Avenue, Pittsburgh, PA 15222-3779
(c)	Citizenship: Pennsylvania
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 34962G208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,635,380
(b)	Percent of class: 13.15 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,635,380
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,635,380
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit "1" Attached
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Federated Hermes, Inc.

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:	10/07/2025

Voting Shares Irrevocable Trust

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	10/07/2025

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	10/07/2025

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	10/07/2025

Thomas R. Donahue

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue
Date:	10/07/2025

Ann C. Donahue

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue
Date:	10/07/2025

J. Christopher Donahue

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue
Date:	10/07/2025

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY

FAQ

What stake did Federated Hermes report in Forte Biosciences (FBRX)?

Federated Hermes and affiliated reporting persons disclosed beneficial ownership of 1,635,380 shares, representing 13.15% of common stock.

Does the filing say Federated Hermes intends to change control of FBRX?

No. The filing certifies the shares were acquired and are held in the ordinary course of business and were not acquired to change or influence control.

Who else is named on the Schedule 13G/A for FBRX?

The Voting Shares Irrevocable Trust and individuals Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue are named, each tied to the same aggregate 1,635,380 share position.

What powers over the shares are reported?

Federated Hermes and the Trust report sole voting power and sole dispositive power over the 1,635,380 shares; the Donahue individuals report shared voting and dispositive power over the same aggregate.

Are there exhibits attached to the filing I should review?

Yes. The filing references Exhibit 1 (classification), Exhibit 2 (joint filing agreement), and Exhibit 3 (power of attorney).